🔎 Trials Near Me

Domov › Rakovina vaječníkov › Kalifornia

Klinické štúdie Rakovina vaječníkov v štáte Kalifornia

105 štúdií pre Rakovina vaječníkov hľadá účastníkov v zariadeniach v štáte Kalifornia.

Mestá v štáte Kalifornia

Oficiálny text štúdie (anglicky)

The Vanguard Study: Testing a New Way to Screen for Cancer

  • Kaiser Permanente-Division of Research, Pleasanton
Prebieha náborVítaní zdravých dobrovoľníkov
Vek 45 až 75 · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT06995898

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

  • Research Site, Los Angeles
  • Research Site, San Francisco
Prebieha náborFáza 1/2
Vek 18 až 130 · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT05417594

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
  • Cedars-Sinai Medical Center, Los Angeles
  • UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
  • a 1 ďalších
Prebieha náborFáza 2/3
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT07001748

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • PCR Oncology, Arroyo Grande
  • Mercy Cancer Center - Carmichael, Carmichael
  • Mercy San Juan Medical Center, Carmichael
  • a 15 ďalších
Prebieha náborFáza 2
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT05564377

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

  • Research Site, Duarte
  • Research Site, Irvine
Prebieha náborFáza 1/2
Vek 18 až 130 · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT05797168

A Study of PHST001 in Advanced Solid Tumors

  • Precision NextGen Oncology & Research Center, Beverly Hills
  • USC Norris Comprehensive Cancer Center, Los Angeles
  • Stanford University School of Medicine, Palo Alto
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 5. 10. 2026 · NCT06840886

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • City of Hope National Medical Center, Duarte
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
  • UCLA Department of Medicine-Hematology/Oncology, Los Angeles
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  • University of San Diego Moores Cancer Center, La Jolla
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
Prebieha náborFáza 1/2
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

  • Kaiser Permanente Dublin, Dublin
  • Kaiser Permanente-Fremont, Fremont
  • Kaiser Permanente Fresno Orchard Plaza, Fresno
  • a 10 ďalších
Prebieha nábor
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07059884

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

  • City of Hope, Duarte
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06172478

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

  • University of California - Los Angeles, Los Angeles
Prebieha náborFáza 1
Vek 19 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06586957

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

  • City of Hope National Medical Center /ID# 281381, Duarte
  • City of Hope - Orange County Lennar Foundation Cancer Center /ID# 280914, Irvine
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT07278336

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

  • Research Site, Duarte
  • Research Site, Los Angeles
  • Research Site, Newport Beach
  • a 1 ďalších
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT05877599

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

  • UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
  • Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
  • California Pacific Medical Center - Van Ness Campus /ID# 275329, San Francisco
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 29. 9. 2026 · NCT06890338

DESTINY-PANTUMOUR04

  • Research Site, San Diego
Prebieha náborObservačná štúdia
Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

  • University of California San Diego, La Jolla
  • Stanford University, Palo Alto
  • UCLA Medical Center, Santa Monica
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT04981119

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

  • Kivu Trial Site, Santa Monica
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT07229313

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

  • City of Hope Comprehensive Cancer Center, Duarte
  • The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
  • Chao Family Comprehensive Cancer Center, Orange
Prebieha náborFáza 1/2
Vek 18 a viac · Ženy · Aktualizované 24. 9. 2026 · NCT04590326

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

  • Research Site, Los Angeles
  • Research Site, Santa Rosa
Prebieha náborFáza 2
Vek 18 až 130 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT05489211

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

  • Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center, Burbank
  • City of Hope, Duarte, Duarte
  • City of Hope Lennar, Irvine
  • a 6 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213804

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Stanford University Medical Center, Stanford
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07213791

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

  • UC San Diego Health - Moores Cancer Center /ID# 277574, La Jolla
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 22. 9. 2026 · NCT07059845

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • UC IRVINE Health, Orange
  • UC Davis Comprehensive Cancer Center, Sacramento
  • Stanford Cancer Institute, Stanford
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT06128551

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Beverly Hills Cancer Center, Beverly Hills
  • City of Hope Cancer Center, Duarte
  • University of California Irvine Medical Center, Orange
  • a 1 ďalších
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 21. 9. 2026 · NCT05983432

BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)

  • City of Hope National Medical Center, Duarte
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT04752826

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

  • John Muir Health Cancer Center ( Site 0069), Walnut Creek
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 17. 9. 2026 · NCT07318558

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

  • City of Hope, Duarte
  • City of Hope, Irvine, Irvine
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 9. 2026 · NCT07109726

Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • City of Hope Medical Center, Duarte
  • Providence Medical Foundation, Fullerton
  • University of California, San Diego-Moores Cancer Center, La Jolla
  • a 3 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 15. 9. 2026 · NCT07214779

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

  • University of California, Los Angeles Medical Center, Los Angeles
  • Scripps Healthscripps Mercy Hospital Prebys Cancer Center, San Diego
Prebieha náborFáza 2
Vek 18 až 99 · Ženy · Aktualizované 15. 9. 2026 · NCT07023627

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

  • University of California, San Diego, La Jolla
  • Hoag Memorial Hospital Presbyterian, Newport Beach
  • Redwood City, Redwood City
Prebieha náborObservačná štúdia
Vek 18 a viac · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT05059444

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

  • UC San Diego Health, La Jolla
  • Cedars Sinai Medical Center, Los Angeles
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 14. 9. 2026 · NCT06787612

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

  • Research Site, Santa Monica
  • Research Site, Santa Rosa
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT05123482

Clinical Trial of Autologous B7-H3 CAR T Cells in Reoccurent Platinum-resistant Ovarian Tumors

  • Stanford University, Palo Alto
Prebieha náborFáza 1
Vek 18 a viac · Ženy · Aktualizované 10. 9. 2026 · NCT06646627

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

  • City of Hope, Duarte
  • START - Los Angeles, Los Angeles
  • Cedars Sinai, Los Angeles
  • a 1 ďalších
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06293898

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 4. 9. 2026 · NCT06400472

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

  • UCSF Medical Center at Mission Bay ( Site 0013), San Francisco
  • John Muir Health Cancer Center ( Site 0016), Walnut Creek
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 3. 9. 2026 · NCT06824467

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

  • UC San Diego Moores Cancer Center, La Jolla
  • University of Southern California, Los Angeles
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07216105

Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer

  • Start Cal, Los Angeles
Prebieha náborFáza 1/2
Vek 18 a viac · Ženy · Aktualizované 1. 9. 2026 · NCT07736937

Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.